2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Vomiting
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Prostate Cancer Prevention
1
Postoperative Nausea and Vomiting
1
Multiple Endocrine Neoplasia Type 1
1
Healthy Volunteers
1
Dermatitis, Contact
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Atypical Squamous Cells of the Cervix
1
Interventions
Fulvestrant
5
Exercise
5
Eating
5
Standard of Care
3
Sodium Chloride
3
Diet
3
Alpelisib
3
ribociclib
2
gallium Ga 68 dotatate
2
exemestane
2
Vitamin D
2
Tamoxifen
2
Magnetic Resonance Spectroscopy
2
Letrozole
2
Ethanol
2
Blood Specimen Collection
2
Anastrozole
2
zopiclone
1
ziprasidone
1
veliparib
1
testosterone undecanoate
1
testosterone enanthate
1
pazopanib
1
mirabegron
1
methyl hydroxyethyl cellulose
1
lenvatinib
1
fluorocholine
1
evolocumab
1
dimethandrolone-undecanoate
1
cyclopropapyrroloindole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Endocrine Neoplasia Type 1
×
Gelatin
×
Clear all
NCT01526759
2012-03-12
FLiTS
Wageningen University
Phase NA
Completed
35 enrolled